The Region - News from April 30, 1987
Three men have been indicted by a federal grand jury in Los Angeles for allegedly manufacturing and distributing about 1,200 bottles of counterfeit Naprosyn, a widely prescribed drug used in treating rheumatoid arthritis and tendinitis. The indictment against Javid Naghdi, an Iranian; Shapour Shahabi of Los Angeles, and Sourin Boudaghians of Glendale, alleges that the three men sold more than 1,100 bottles of a drug labeled as Naprosyn but which contained mostly aspirin and acetaminophen. Each defendant faces a maximum of 51 years in prison if convicted.
More to Read
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
